For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Glycoproteins are proteins that contain oligosaccharide chains (glycans) covalently attached to polypeptide side-chains. The carbohydrate is attached to the protein in a cotranslational or posttranslational modification. This process is known as glycosylation. Secreted extracellular proteins are often glycosylated.
Scope of the Report:
As international economic situation is complicated, in the next few years there will be many uncertainties. Due to the government' policy and the high consumption of Glycoprotein in the international market, the current demand for Glycoprotein product is relatively large in the mature market, such as North America and Europe, but in developing countries, the level of health care is very low.
Glycoprotein is mainly manufactured and sold by Sigma, Creative Diagnostics, R&D Systems, Enzo Life Sciences, Thermo Fisher Scientific, Epitope Diagnostics, BD Biosciences; and these companies occupied about 91.08% market share in 2016.
Geographically, North America is the largest sales market in the world, which took about 51.88 percent of the global consumption volume in 2016.
The worldwide market for Glycoprotein is expected to grow at a CAGR of roughly 1.3% over the next five years, will reach 490 million US$ in 2024, from 460 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Glycoprotein in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Sigma
- Creative Diagnostics
- R&D Systems
- Enzo Life Sciences
- Thermo Fisher Scientific
- Epitope Diagnostics
- BD Biosciences
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- N-linkage
- O-linkage
- Other
Market Segment by Applications, can be divided into
- Hospital
- Research Institutes
- Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glycoprotein product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Glycoprotein, with price, sales, revenue and global market share of Glycoprotein in 2017 and 2018.
Chapter 3, the Glycoprotein competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glycoprotein breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Glycoprotein market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Glycoprotein sales channel, distributors, customers, research findings and conclusion, appendix and data source.